Jan. 12, 2022
NRx Pharmaceuticals Files Counterclaim Against its Former Collaboration Partner, Relief Therapeutics
NRx Pharmaceuticals (Nasdaq: NRXP) filed a lawsuit on Monday against Relief Therapeutics (SIX: RLF,OTCQB: RLFTF, RLFTY), its former collaboration partner, in New York State Supreme Court.